893
edits
Changes
Jump to navigation
Jump to search
→Pregnant Patients Undergoing Diagnostic Radiology
If the examinations are justified and their performance is optimised, they should not be withheld from pregnant patients. Fetal dose reduction measures will vary depending on the specific test being administered, but may include reducing the dose of injected radiopharmaceutical, limiting the number of images performed, beam collimation, patient shielding, and ensuring that the maternal pelvis (and fetus) is not in the beam path during fluoroscopic procedures unless it is absolutely necessary.
A pregnant patient has a right to know the magnitude and type of potential radiation effects that may result from in-utero exposure. Benefits and risks of the examination should be discussed with the patient, including developmental and cancer risks to the unborn baby. Central nervous system malformations and intellectual deficits have only been reported at fetal doses >100 mSv. Fetal doses from routine medical imaging are generally well below 100 mSv, and are generally below 20 mSv (<ref>Radiation dose management: part 2, estimating fetal radiation risk from CT during pregnancy.[https://www.ncbi.nlm.nih.gov/pubmed/22451572|title]).</ref>
====Pregnant Patients Undergoing Radiation Therapy====
